奈诺沙星是一种非氟喹诺酮类抗生素,正在进行临床试验。它具有与氟喹诺酮类药物相同的作用机制;它抑制DNA回旋酶,防止DNA合成、基因复制和细胞分裂。到2016年底,它已经以Taigexyn的品牌在台湾、俄罗斯、英联邦独立国家、土耳其、中国大陆和拉丁美洲进入市场。奈诺沙星在美国完成了2期试验,并进行了3期临床试验。美国食品和药物管理局(FDA)已经批准了奈莫沙星合格传染病产品(QIDP)和社区获得性细菌性肺炎(CAP)和急性细菌性皮肤和皮肤结构感染(ABSSSI)的快速追踪标识。

清空选项
221221-16-5 1-Cyclopropyl-7-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
BD248185221221-16-597%
¥3124.001g常备现货
1071-46-1 3-Ethoxy-3-oxopropanoic acid
BD1293601071-46-197%
¥809.00500g常备现货
221220-99-1 3-Bromo-2,6-difluorophenol
BD231023221220-99-198%
¥321.001g常备现货
221221-15-4 Ethyl 1-cyclopropyl-7-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate
BD330935221221-15-495%
¥4630.001g常备现货
348-57-2 1-Bromo-2,4-difluorobenzene
BD33332348-57-297%
¥80.00100g常备现货
53100-44-0 Boc-Pyr-OH
BD2125153100-44-095%
¥467.00100g常备现货
364-83-0 2',4'-Difluoroacetophenone
BD33406364-83-097%
¥939.00500g常备现货
108963-96-8 1-(tert-Butyl) 2-methyl (S)-5-oxopyrrolidine-1,2-dicarboxylate
BD17481108963-96-897%
¥30.0025g常备现货
951163-61-4 tert-Butyl ((3S,5S)-5-methylpiperidin-3-yl)carbamate
BD119945951163-61-498%
¥3337.001g常备现货
378746-64-6 7-((3S,5S)-3-Amino-5-methylpiperidin-1-yl)-1-cyclopropyl-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
BD01368570378746-64-698%
¥1202.001mg常备现货
951163-65-8 1-(2,4-Difluoro-3-hydroxyphenyl)ethanone
BD458570951163-65-897%
¥8953.001g
221221-11-0 2,4-Difluoro-3-methoxybenzoyl chloride
BD319678221221-11-095+%
¥1150.001g
221221-00-7 1-Bromo-2,4-difluoro-3-methoxybenzene
BD219129221221-00-795+%
¥2769.001g
178974-97-5 2,4-Difluoro-3-methoxybenzoic acid
BD5928178974-97-598%
¥185.001g
373603-19-1 1-(2,4-Difluoro-3-methoxyphenyl)ethanone
BD66835373603-19-197%
¥1108.001g
882406-40-8 2-(2,4-Difluorophenyl)-2-methyl-1,3-dioxolane
BD01119485882406-40-895%
¥455.001g
196394-48-6 1-(tert-Butyl) 2-methyl (2S,4S)-4-methyl-5-oxopyrrolidine-1,2-dicarboxylate
BD01363795196394-48-698%
¥2577.00100mg
1